1 Min Read
June 5 (Reuters) - Fibrogen Inc:
* European patent office maintains fibrogen patent relating to Hypoxia-Inducible Factor (HIF) Prolyl Hydroxylase inhibitor technology Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.